| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a80cbaaeee718664126e579cf4e41c2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 |
| filingDate |
2016-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0dbcc7f4b4d5333f54cf6c92b6eee7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15e1f93f8225a28f01368cfd5dd22240
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d6ddbc6a01b364b72bd01042fb5768b |
| publicationDate |
2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CL-2016001794-A1 |
| titleOfInvention |
Method for administering tasimelteon to a human patient that includes oral administration of an effective dose under fasting conditions to treat a circadian rhythm disorder or a sleep disorder, such as sleep-wake disorder other than 24 hours non-24 method for shorten the tmax of tasimelteon in a human patient who is being treated with tasimelteon. |
| abstract |
METHOD TO ADMINISTER TASIMELTEON TO A HUMAN PATIENT THAT INCLUDES ORAL ADMINISTRATION OF AN EFFECTIVE DOSE IN CONDITIONS OF FAST TO TREAT A DISORDER OF THE CIRCADIAN RHYTHM OR A DISORDER OF THE DREAM, LIKE THE DISORDER OF THE SLEEP-24 TO 24 SHORT THE Tmax OF TASIMELTEON IN A HUMAN PATIENT WHO IS BEING TREATED WITH TASIMELTEON. |
| priorityDate |
2014-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |